Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis: A Modified Delphi Study.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
03 2023
Historique:
received: 01 07 2022
revised: 10 10 2022
accepted: 26 10 2022
pubmed: 8 11 2022
medline: 14 3 2023
entrez: 7 11 2022
Statut: ppublish

Résumé

The diagnosis of constrictive bronchiolitis (CB) in previously deployed individuals, and evaluation of respiratory symptoms more broadly, presents considerable challenges, including using consistent histopathologic criteria and clinical assessments. What are the recommended diagnostic workup and associated terminology of respiratory symptoms in previously deployed individuals? Nineteen experts participated in a three-round modified Delphi study, ranking their level of agreement for each statement with an a priori definition of consensus. Additionally, rank-order voting on the recommended diagnostic approach and terminology was performed. Twenty-five of 28 statements reached consensus, including the definition of CB as a histologic pattern of lung injury that occurs in some previously deployed individuals while recognizing the importance of considering alternative diagnoses. Consensus statements also identified a diagnostic approach for the previously deployed individual with respiratory symptoms, distinguishing assessments best performed at a local or specialty referral center. Also, deployment-related respiratory disease (DRRD) was proposed as a broad term to subsume a wide range of potential syndromes and conditions identified through noninvasive evaluation or when surgical lung biopsy reveals evidence of multicompartmental lung injury that may include CB. Using a modified Delphi technique, consensus statements provide a clinical approach to possible CB in previously deployed individuals. Use of DRRD provides a broad descriptor encompassing a range of postdeployment respiratory findings. Additional follow-up of individuals with DRRD is needed to assess disease progression and to define other features of its natural history, which could inform physicians better and lead to evolution in this nosology.

Sections du résumé

BACKGROUND
The diagnosis of constrictive bronchiolitis (CB) in previously deployed individuals, and evaluation of respiratory symptoms more broadly, presents considerable challenges, including using consistent histopathologic criteria and clinical assessments.
RESEARCH QUESTION
What are the recommended diagnostic workup and associated terminology of respiratory symptoms in previously deployed individuals?
STUDY DESIGN AND METHODS
Nineteen experts participated in a three-round modified Delphi study, ranking their level of agreement for each statement with an a priori definition of consensus. Additionally, rank-order voting on the recommended diagnostic approach and terminology was performed.
RESULTS
Twenty-five of 28 statements reached consensus, including the definition of CB as a histologic pattern of lung injury that occurs in some previously deployed individuals while recognizing the importance of considering alternative diagnoses. Consensus statements also identified a diagnostic approach for the previously deployed individual with respiratory symptoms, distinguishing assessments best performed at a local or specialty referral center. Also, deployment-related respiratory disease (DRRD) was proposed as a broad term to subsume a wide range of potential syndromes and conditions identified through noninvasive evaluation or when surgical lung biopsy reveals evidence of multicompartmental lung injury that may include CB.
INTERPRETATION
Using a modified Delphi technique, consensus statements provide a clinical approach to possible CB in previously deployed individuals. Use of DRRD provides a broad descriptor encompassing a range of postdeployment respiratory findings. Additional follow-up of individuals with DRRD is needed to assess disease progression and to define other features of its natural history, which could inform physicians better and lead to evolution in this nosology.

Identifiants

pubmed: 36343686
pii: S0012-3692(22)04047-8
doi: 10.1016/j.chest.2022.10.031
pmc: PMC10154857
pii:
doi:

Types de publication

Practice Guideline Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

599-609

Subventions

Organisme : CSRD VA
ID : IK2 CX001779
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH008429
Pays : United States
Organisme : NHLBI NIH HHS
ID : UH3 HL152323
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

F1000 Med Rep. 2010 Apr 27;2:
pubmed: 20948853
N Engl J Med. 2011 Jul 21;365(3):222-30
pubmed: 21774710
JAMA. 2018 Sep 11;320(10):1074
pubmed: 30208457
Semin Respir Crit Care Med. 2015 Jun;36(3):366-78
pubmed: 26024345
Radiographics. 2015 Sep-Oct;35(5):1360-80
pubmed: 26274445
Am J Surg Pathol. 2021 Dec 1;45(12):1587-1596
pubmed: 34081035
Chest. 2013 May;143(5):1436-1443
pubmed: 23648907
J Occup Environ Med. 2012 Jan;54(1):1-2
pubmed: 22227868
J Clin Epidemiol. 2014 Apr;67(4):401-9
pubmed: 24581294
Ther Adv Respir Dis. 2013 Aug;7(4):235-45
pubmed: 23470637
Radiology. 2022 Jul;304(1):185-192
pubmed: 35289657
Curr Opin Pulm Med. 2015 Mar;21(2):185-92
pubmed: 25575366
J Occup Environ Med. 2012 Jun;54(6):746-51
pubmed: 22588477
J Occup Environ Med. 2020 May;62(5):337-343
pubmed: 31977922
Palliat Med. 2017 Sep;31(8):684-706
pubmed: 28190381
N Engl J Med. 2022 Apr 7;386(14):1352-1357
pubmed: 35388671
BMC Pulm Med. 2022 Apr 27;22(1):163
pubmed: 35477425
J Thorac Imaging. 2022 Mar 1;37(2):117-124
pubmed: 34121086
Am J Respir Crit Care Med. 2022 Sep 15;206(6):786-789
pubmed: 35608541
N Engl J Med. 2011 Oct 27;365(17):1567-75
pubmed: 22029978
Mil Med. 2020 Dec 30;185(11-12):472-475
pubmed: 32761145
Chest. 2020 Jun;157(6):1559-1567
pubmed: 32017933
Ann Am Thorac Soc. 2019 Aug;16(8):e1-e16
pubmed: 31368802
Lung. 2021 Aug;199(4):345-355
pubmed: 34363506
J Occup Environ Med. 2011 Sep;53(9):961-5
pubmed: 21866049
Ann Am Thorac Soc. 2018 Dec;15(12):1411-1419
pubmed: 30339479
Mil Med. 2002 Apr;167(4):281-8
pubmed: 11977877
Hum Pathol. 2022 Jun;124:56-66
pubmed: 35240130

Auteurs

Michael J Falvo (MJ)

Airborne Hazards and Burn Pits Center of Excellence, Department of Veterans Affairs New Jersey Health Care System, East Orange, NJ; New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, NJ. Electronic address: Michael.Falvo@va.gov.

Anays M Sotolongo (AM)

Airborne Hazards and Burn Pits Center of Excellence, Department of Veterans Affairs New Jersey Health Care System, East Orange, NJ; New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, NJ.

John J Osterholzer (JJ)

Pulmonary Section, Department of Medicine, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI; Division of Pulmonary and Critical Care, Department of Medicine, University of Michigan, Ann Arbor, MI.

Michelle W Robertson (MW)

Airborne Hazards and Burn Pits Center of Excellence, Department of Veterans Affairs New Jersey Health Care System, East Orange, NJ.

Ella A Kazerooni (EA)

Department of Radiology, University of Michigan, Ann Arbor, MI; Department of Internal Medicine, University of Michigan, Ann Arbor, MI.

Judith K Amorosa (JK)

Department of Radiology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; University Radiology Group, East Brunswick, NJ.

Eric Garshick (E)

Pulmonary, Allergy, Sleep, and Critical Care Medicine Section, Veterans Affairs Boston Healthcare System, Boston, MA; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA.

Kirk D Jones (KD)

Department of Anatomic Pathology, University of California, San Francisco, CA.

Jeffrey R Galvin (JR)

Department of Radiology and Nuclear Medicine (Chest Imaging), University of Maryland School of Medicine, Baltimore, MD.

Kathleen Kreiss (K)

Respiratory Health Division, National Institute for Occupational Safety and Health, Morgantown, WV.

Stella E Hines (SE)

Divisions of Occupational and Environmental Medicine and Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD; VA Maryland Health Care System, Baltimore Veterans Affairs Medical Center, Baltimore, MD.

Teri J Franks (TJ)

Department of Pulmonary and Mediastinal Pathology, Joint Pathology Center, Department of Defense, Silver Spring, MD.

Robert F Miller (RF)

Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.

Cecile S Rose (CS)

Division of Environmental and Occupational Health Sciences, National Jewish Health, Denver, CO; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Denver, CO.

Mehrdad Arjomandi (M)

Department of Anatomic Pathology, University of California, San Francisco, CA; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, CA.

Silpa D Krefft (SD)

Division of Environmental and Occupational Health Sciences, National Jewish Health, Denver, CO; Division of Pulmonary and Critical Care Medicine, Veterans Administration Eastern Colorado Health Care System, Aurora, CO; Division of Pulmonary and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO.

Michael J Morris (MJ)

Pulmonary/Critical Care Service, Department of Medicine, Brooke Army Medical Center, JBSA-Sam Houston, Fort Sam Houston, TX.

Vasiliy V Polosukhin (VV)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.

Paul D Blanc (PD)

Department of Anatomic Pathology, University of California, San Francisco, CA; Division of Occupational and Environmental Medicine, University of California, San Francisco, CA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.

Jeanine M D'Armiento (JM)

Center for LAM and Rare Lung Disease, Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH